The Latest Breaking News from Obesity

"It is critical to note that research on the long-term effects of these newer weight loss drugs is limited"

If the buzz surrounding a medication could elevate it to celebrity status, then Zepbound is reaching Taylor Swift rank.

In popular discussions of healthy eating, including political rhetoric and nutrition counselling, women are often blamed for a lack of nutrition knowledge or cooking skills, leading to the assumption that a decline in cooking skills is connected with unhealthy diets and obesity. This has been called a “deficit approach” and…

Fertility clinics bar women with obesity from their services, despite the lack of medical evidence for doing so

Light physical activity appears to be the antidote to the catastrophic effect of sedentary time in the young population. Read further on Dynamite News:

Many firms see the dire forecasts as ‘overblown’ but they know they will have to adapt products to make ‘every bite counts’

Hold onto your hats, folks, because there's some fascinating news in the world of diabetes and obesity drugs! A recent federal study found that people taki...

A new federal study finds that people taking popular diabetes and obesity drugs Ozempic and Wegovy had a lower risk of suicidal thoughts than those taking other medications to treat the same conditions

Biotech stocks are heating up as multibillion-dollar deals pile up and new modalities like CRISPR gene-editing hit prime time.

Despite higher rates of childhood obesity, Hunter families are using fewer sports vouchers.

Eli Lilly has launched a unique website to connect U.S. patients seeking obesity treatment to doctors, dieticians and its new weight-loss drug, Zepbound